Evidence map›Paper›PMID 39305199›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2024

Epidermal renewal during the treatment of atopic dermatitis lesions: A study coupling line-field confocal optical coherence tomography with artificial intelligence quantifications: LC-OCT reveals new biological markers of AD.

Heiva Le Blay, Edouard Raynaud, Sonia Bouayadi, Elodie Rieux, Géraldine Rolland, Anne Saussine, Marie Jachiet, Jean-David Bouaziz, Barbara Lynch

Abstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Epidermal renewal during the treatment of atopic dermatitis lesions: A study coupling line-field confocal optical coherence tomography with artificial intelligence quantifications: LC-OCT reveals new biological markers of AD.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heiva Le BlayBioclinical Research Center (BRC) of L'Oréal Advanced Research, Saint-Louis Hospital, Paris, France.ORCID https://orcid.org/0009-0007-4784-5093
Edouard RaynaudBioclinical Research Center (BRC) of L'Oréal Advanced Research, Saint-Louis Hospital, Paris, France.ORCID https://orcid.org/0000-0002-4253-5439
Sonia BouayadiBioclinical Research Center (BRC) of L'Oréal Advanced Research, Saint-Louis Hospital, Paris, France.
Elodie RieuxBioclinical Research Center (BRC) of L'Oréal Advanced Research, Saint-Louis Hospital, Paris, France.
Géraldine RollandBioclinical Research Center (BRC) of L'Oréal Advanced Research, Saint-Louis Hospital, Paris, France.
Anne SaussineDermatologie, Saint-Louis Hospital AP-HP, Paris, France.
Marie JachietDermatologie, Saint-Louis Hospital AP-HP, Paris, France.
Jean-David BouazizDermatologie, Saint-Louis Hospital AP-HP, Paris, France.
Barbara LynchBioclinical Research Center (BRC) of L'Oréal Advanced Research, Saint-Louis Hospital, Paris, France.

Funding

L'Oréal Research and Innovation, Advanced Research
6 · The paper itself

Abstract

objectiveThis study explores the application of Line-field Confocal Optical Coherence Tomography (LC-OCT) imaging coupled with artificial intelligence (AI)-based algorithms to investigate atopic dermatitis (AD), a common inflammatory dermatosis. MATERIALS AND

methodsAD acute and chronic lesions (ADL) were compared to clinically healthy-looking skin (ADNL). LC-OCT was used noninvasively and in real-time to image the skin of AD patients during flare-ups and monitor remissions under topical steroid treatment for 2 weeks. Quantitative parameters were extracted from the images, including morphological and cellular-level markers of epidermal architecture. A novel cellular-level parameter, nuclei "atypia," which quantifies the orderliness of epidermal renewal, was used to highlight abnormal maturation processes.

resultsCompared to healthy skin, AD lesions exhibited significant increases in both epidermal and stratum corneum (SC) thickness, along with a more undulated dermo-epidermal junction (DEJ). Additionally, keratinocyte nuclei (KN) were larger, less compact, and less organized in lesional areas, as indicated by the atypia parameter. A higher degree of atypia was observed in chronic lesions compared to acute ones. Following treatment, all the parameters normalized to levels observed in healthy skin within 2 weeks, mirroring clinical improvements.

conclusionThis study provides insights into the quantification of epidermal renewal using a noninvasive imaging technique, highlighting differences between ADL/ADNL and acute/chronic lesions. It also presents the AD treatment mechanism, paving the way for future investigations on AD and other skin barrier function-related conditions.

Indexed as

Artificial IntelligenceDermatitis, AtopicEpidermisTomography, Optical CoherenceAdultAlgorithmsBiomarkersFemaleHumansMaleMiddle AgedYoung AdultBiomarkersartificial intelligenceatopic dermatitisbiomarkerscorticosteroidsepidermisLC‐OCT

Identifiers

PMID39305199
PMCPMC11415820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.